Biogen Inc (BIIB) News: Latest Market and Industry Updates
229.41
3.65
1.62 %
At close
10/12
USD
Daily range
229.18
236.50
236.50
Weekly range
216.00
236.50
236.50
Will Biogen stock break $244.34 resistance as buyer support remains firm?
Biogen (BIIB) stock is trading at $234.53, having risen 3.88% on the day in a high volatility session. The price currently sits above its key moving averages, signaling ...
Biogen upgrade points to pipeline trial catalysts and share upside
Biogen is entering a period of closely watched clinical updates that JPMorgan says could strengthen investor confidence in its growth outlook. The bank upgrades the biotech stock to overweight and ...
BIIB rallies as mixed signals suggest market indecision
Biogen Inc. (BIIB) stock is trading at $225.82, up 3.38% on the day. The price is positioned above its key moving averages, reflecting supportive conditions across ...
Biogen stock rally: Upside targets to watch
Biogen Inc. (BIIB) stock is trading at $226.1, up 3.12% on the day. The stock sits above its key moving averages with strong intraday momentum and has closed near the ...
U.S. stocks rise on company updates and deal speculation at midday
Midday trading in U.S. equities is being driven by a mix of corporate disclosures, clinical trial results and takeover speculation across sectors. Gains are concentrated in housing, biotech, ...
ADARx Pharmaceuticals targets up to $1.74 billion valuation in U.S. IPO
Biotech listing activity is showing renewed momentum as ADARx Pharmaceuticals moves ahead with plans to go public in the U.S. The San Diego-based company is seeking to raise up to $371.9 million, ...
Biogen stock challenges $226.49 resistance as 4-year zorevunersen study data lifts sentiment
Biogen (BIIB) stock is trading at $222.74, rising 3.1% intraday and holding firmly above its major short-, mid-, and long-term moving averages. The price action shows ...
What's behind Biogen's latest 3.6% stock surge?
Biogen Inc (BIIB) surged 3.62% after the company completed its acquisition of RayThera, adding momentum to the stock as investors responded to recent M&A and earnings developments. The move is ...
Charles River Laboratories gains JPMorgan upgrade as biotech funding recovery supports outlook
Renewed capital flows into biotechnology are improving demand visibility for contract research providers and lifting sentiment around Charles River Laboratories. The company has also raised its ...
Biogen shares drop over 8% after mixed Alzheimer's trial data and FDA move
Biogen Inc (BIIB) dropped 8.21% after new clinical results and an FDA approval on Alzheimer's programs highlighted increased volatility in trading. The move is supported by the stock's failure to ...
BIIB slips as weak momentum keeps sellers in control
Biogen Inc. (BIIB) stock is trading at $193.75, marking a sharp decline of 7.31% on the day. The price currently sits below its key short- and medium-term moving ...
Biogen stock price forecast: $174.41 support comes into view as BIIB slips 1.94%
Biogen Inc. (BIIB) stock is trading at $194.83, down 1.94% on the day and closing near its intraday low. The recent decline places the share price below its key short- ...
